© 2024 Blaze Media LLC. All rights reserved.
World Health Organization will rename monkeypox to avoid stigma and racism
Smith Collection/Gado/Getty Images

World Health Organization will rename monkeypox to avoid stigma and racism

World Health Organization officials will meet in emergency session next week to evaluate the international outbreak of monkeypox and determine whether the virus should be considered a global health emergency. They will also rename the virus after scientists raised concerns that the name "monkeypox" is racist, officials said.

WHO Director-General Tedros Adhanom Ghebreyesus said Tuesday the U.N. health agency's emergency committee will meet on June 23 to discuss the outbreak, which he called "unusual and concerning."

"For that reason, I have decided to convene the Emergency Committee under the international Health Regulations next week, to assess whether this outbreak represents a public health emergency of international concern," Tedros said during a media briefing.

The WHO director-general announced there have been more than 1,600 confirmed cases and nearly 1,500 suspected cases of monkeypox reported this year from 39 countries, including seven countries where the virus has been found before and 32 newly affected countries.

"So far this year, 72 deaths have been reported from previously affected countries. No deaths have been reported so far from the newly affected countries, although WHO is seeking to verify news reports from Brazil of a monkeypox-related death there," Tedros said.

"WHO's goal is to support countries, contain transmission, and stop the outbreak with tried-and-tested public health tools including surveillance, contact tracing, and isolation of infected patients," he added.

To that end, the WHO published interim guidance for public health agencies to follow. The guidance states that mass vaccination is not yet required or recommended for monkeypox and that smallpox or monkeypox vaccines should be used on a case-by-case basis after a full assessment of their potential risks and benefits for each patient.

"While smallpox vaccines are expected to provide some protection against monkeypox, there is limited clinical data and limited supply," Tedros said. "Any decision about whether to use vaccines should be made jointly by individuals who may be at risk and their health care provider, based on an assessment of risks and benefits, on a case-by-case basis."

The director-general added that the WHO is "working with partners and experts from around the world on changing the name of monkeypox virus, its clades and the disease it causes."

More than 30 international scientists wrote an open letter last week stating there was an "urgent need for a non-discriminatory and non-stigmatizing" name for monkeypox. They argued that news reports referring to the virus as an "African" virus were discriminatory and stigmatizing. A WHO spokesperson told Bloomberg that the organization's guidelines recommend against using geographic regions and animal names to describe disease-causing pathogens.

Tedros said the name changes will be announced as soon as possible.

There have been 65 confirmed monkeypox cases in the United States as of June 13, according to the Centers for Disease Control and Prevention. A recent outbreak in Chicago was linked to the International Mr. Leather conference, a BDSM convention held between May 26 and 30.

International health experts have linked the spread of monkeypox to communities of men who have sex with men, but the virus is not a sexually transmitted disease. It is spread by skin-to-skin contact with someone who has monkeypox sores, as well as by direct contact with materials that have touched body fluids or sores, including clothing.

Want to leave a tip?

We answer to you. Help keep our content free of advertisers and big tech censorship by leaving a tip today.
Want to join the conversation?
Already a subscriber?